Introduction
A growing list of inherited human syndromes results from mutations in genes that control different aspects of ribosome synthesis and are characterized by cancer susceptibility Ganapathi and Shimamura, 2008; Alter et al, 2009 ). X-linked dyskeratosis congenita (X-DC) is invariably associated with mutations of the DKC1 gene encoding for the dyskerin protein, which functions as a pseudouridine synthase that mediates post-transcriptional modification of ribosomal RNA (rRNA) when associated with the H/ACA class of small nucleolar RNAs (Meier, 2005) . Other, milder forms of dyskeratosis congenita can arise from mutations in genes affecting other molecular pathways, including components of the telomerase complex that are also found to be associated with dyskerin (Kirwan and Dokal, 2008) . Importantly, we have genetically shown by recapitulating X-DC pathogenesis in DKC1 hypomorphic mice (DKC1 m ) that impairments in rRNA modifications are associated with X-DC pathogenesis when telomeres are of a normal length . Strikingly, more than 50% of DKC1 m mice develop tumours with different histological origins, consistent with increased cancer susceptibility present in X-DC patients . DKC1 m mice as well as X-DC human patient cells show a selective impairment in the translation of a subset of mRNAs that share a common mode of translation initiation relying on an internal ribosome entry site (IRES) element positioned in their 5 0 untranslated region (Yoon et al, 2006) . However, the tumour suppressive function of DKC1 is poorly understood, and there is a major gap in our understanding of the molecular events underlying cancer initiation or progression in X-DC.
IRES-dependent translation is a fine-tuning mechanism that regulates the expression of important proteins in specific circumstances when a general decrease in cap-dependent translation is evident, such as during the mitotic phase of the cell cycle, hypoxia, and apoptosis. A balance between cap-and IRES-dependent translation is, therefore, required to maintain accurate cellular homeostasis (Holcik and Sonenberg, 2005) . Cellular senescence is an effective and rapid anti-tumour barrier that acts by restraining the uncontrolled proliferation of cells that are carrying potentially oncogenic alterations, such as the H-Ras V12 oncogene (Artandi and Attardi, 2005) . In this study, we identify a new mechanism by which a selective switch between capand IRES-mediated translation modulates gene expression in cells undergoing oncogene-induced senescence (OIS). These findings link IRES-dependent translational control with the earliest tumour suppressive response against oncogenic insult. We further show that p53, which harbours an IRES element (Ray et al, 2006; Yang et al, 2006) , is translationally regulated during OIS through this mechanism. Importantly, DKC1 m cells display impairments in undergoing cellular senescence after expression of an activated H-Ras V12 oncogene and bypass OIS-induced cell cycle arrest, which results in a dramatic increase in their clonogenic potential. At the molecular level, this defect is associated with impaired IRESdependent translational control of p53 expression during OIS and DNA damage. Moreover, X-DC human patient cells that harbour mutations in the DKC1 gene also show similar defects in p53 IRES-dependent translation, which are associated with a significant decrease in p53 protein expression. Importantly, re-introduction of an exogenous wild-type DKC1 (DKC1 WT ) into these cells was able to restore p53 expression levels, thus further showing the importance of DKC1 in the regulation of p53 translational control. Altogether, these results provide a novel mode for regulating gene expression during the early steps of cellular transformation, highlighting the importance of p53 translational control and helping to explain how DKC1 functions as a tumour suppressor gene.
Results
A translational switch from cap-to IRES-dependent translation occurs during OIS Oncogenic Ras triggers premature senescence in primary cells (Serrano et al, 1997) . Induction of senescence is a frequent outcome of oncogenic insult and serves as a critical and cellautonomous tumour suppressive mechanism (Artandi and Attardi, 2005) . Although the cellular events during OIS are well established, the molecular mechanisms that regulate gene expression during OIS are poorly understood. Specifically, although the initial effect of oncogenic Ras in normal cells is to trigger proliferation, this aberrant proliferation is not sustained, and after a few doublings, cells enter into a permanent cell cycle arrest indicative of senescence (Serrano et al, 1997) . Until now, translational control of gene expression has not been implicated in this process, but may facilitate a more immediate, rapid, and robust mechanism to counteract oncogenic activation. To address this question, we have generated an animal model that expresses a stable, genetically encoded translational reporter for cap-and IRESdependent translation (CMV-hepatitis C virus (HCV)-IRES T ). The CMV-HCV-IRES T mice harbour a dicistronic mRNA in which the first cistron (Rluc) is translated through capdependent translation and the second cistron (Fluc) is translated under the control of the HCV IRES element IRES T ( Figure 1A ). The HCV IRES element was selected because it provides a general readout of IRES-dependent translation activity and, therefore, represents a great tool to quantify differences in overall IRES-dependent translation initiation. Primary cells from this mouse can be isolated, and this provides a means to accurately monitor translational control in distinct cell types such as mouse embryo fibroblasts (MEFs), in which the integrity of the transgenic vector has been carefully characterized (Supplementary Figure S1 ). Using this genetic reporter, we uncovered that a 'translational switch' between cap-and IRES-dependent translation occurs during RAS-induced senescence.
Early passage HCV IRES T MEFs were transduced with retroviruses harbouring an activated H-Ras V12 oncogene (herein after referred to as RAS), and IRES-and cap-dependent translation were monitored during the process of OIS ( Figure 1A ; Supplementary Figure S1A ). We observed that while cap-dependent translation is initially upregulated after RAS expression, and is associated with an initial burst in proliferation, it steadily decreases during the process of OIS. In contrast, IRES-mediated translation levels are initially very low, but markedly increase during the process of OIS ( Figure 1A ; Supplementary Figure S1A ). These findings show that a translational switch between cap-and IRESdependent translation operates during OIS and may be important in modulating gene expression required to counteract oncogenic insult.
OIS is impaired in DKC1 m cells
We reasoned that defects in IRES-mediated translation that are present in DKC1 m mice and X-DC patient cells (Yoon et al, 2006) might unbalance the synthesis of proteins that are important for OIS induction. Therefore, we first studied OIS in primary DKC1 m MEFs. To this end, early passage WT and DKC1 m MEFs were transduced with control or RAS viruses and the number of senescent b-galactosidase-positive cells was determined 6 days post-pharmacological selection ( Figure 1B and C) . Strikingly, we found that in the presence of RAS, the number of DKC1 m senescent cells was significantly reduced compared with control cells ( Figure 1C ; Supplementary Figure S2C ). Senescence is characterized by irreversible cell cycle arrest, and overexpression of RAS consistently inhibits the growth of WT cells during this process ( Figure 1D ). In contrast, DKC1 m cells proliferate at a higher rate when compared with RAS-infected controls ( Figure 1D ). Importantly, defects in OIS induction that are present in DKC1 m cells are associated with a dramatic increase in clonogenic potential upon overexpression of only a single oncogene that is more than four-fold higher than that of WT cells ( Figure 1E ). These results strongly suggest that DKC1 may act as a tumour suppressor gene, at least in part, through control of OIS.
RAS-induced activation of p53 is defective in DKC1 m cells
The p53 tumour suppressor gene is a master regulator of OIS (Serrano et al, 1997) . Loss of p53 can revert the senescence phenotype elicited by oncogene activation in vivo (Braig et al, 2005; Chen et al, 2005; Collado et al, 2005) . Induction of p53 is rapidly observed after expression of oncogenic RAS in primary cells, and p53 null cells are resistant to RAS-induced senescence (Serrano et al, 1997; Lin et al, 1998) . This prompted us to examine p53 expression in WT and DKC1 m cells during RAS-induced senescence. Strikingly, we found that RAS-dependent p53 accumulation is reduced in DKC1 m cells at all time points studied after pharmacological selection of RAS-infected cells (Figure 2A ). Induction of p53 activity during senescence is associated with growth arrest, at least in part, through activation of p53 target genes, including cell cycle inhibitors (Serrano et al, 1997; Lin et al, 1998) . We tested whether the decrease in p53 expression present in DKC1 m cells would manifest itself in changes in downstream targets. We found that p53-dependent activation of the cell cycle inhibitors p21 cip and GADD45 after RAS expression was substantially reduced in DKC1 m cells ( Figure 2E ). Importantly, stable overexpression of an exogenous WT DKC1 in RAS-infected primary DKC1 m MEFs was able to rescue p53 protein levels and to restore OIS induction (Supplementary Figure S3A and B) .
We next sought to understand the molecular mechanism by which OIS-dependent p53 induction is impaired in DKC1 m cells. One of the main mechanisms by which oncogenic RAS activation engages the p53 pathway in primary murine cells is through induction of the ARF tumour suppressor gene, which positively regulates the stability of the p53 protein (Palmero et al, 1998; Lin and Lowe, 2001; Efeyan et al, 2009) . We therefore first analysed the expression of ARF on transduction of oncogenic RAS. ARF expression is similarly induced in WT and DKC1 m cells during OIS ( Figure 2B ). Furthermore, we blocked total protein neosynthesis using that upstream signals activated during OIS that regulate p53 transcription and/or stability are unperturbed in DKC1 m cells and cannot account for the decrease in p53 protein levels evident in these cells.
p53 IRES-mediated translation is active during senescence and reduced in DKC1 m cells
We next asked whether impairments in DKC1 might affect p53 translational control during OIS. We therefore directly monitored the association between p53 mRNA and polyribosomes in WT and DKC1 m cells in the context of OIS ( Figure 3A ). Importantly, we found that the amount of p53 mRNA associated with polysomes was markedly augmented during OIS in WT cells. Strikingly, this upregulation in polysomal p53 mRNA levels was completely abrogated in RASinfected DKC1 m cells ( Figure 3A , top panels). Notably, the analysis of b-actin mRNA did not reveal significant differences in the polysomal distribution between WT and DKC1 m cells, but it did show that the levels of this messenger associated with polysomal fractions were reduced during OIS ( Figure 3A , bottom panels). Taken together, these results strongly suggest that a specific defect in p53 translational control is present in DKC1 m cells during OIS. Interestingly, p53 has been shown to possess an IRES element (Ray et al, 2006; Yang et al, 2006) ; however, p53 IRES activity during the senescence programme has not been earlier characterized. We therefore monitored p53 IRES-dependent activity during OIS. At first, we used the wellestablished dicistronic expression system in which the first cistron is translated by a cap-dependent initiation mechanism cip and GADD45 mRNA levels during OIS in WT and DKC1 m cells. p21 and GADD45 mRNA levels were measured 6 days post-selection using Q-PCR and normalized over the amount of b-actin messenger in each sample. Graphs show mean ± s.e.m. of a representative experiment performed in triplicate. and the second is translated by the preceding p53 IRES element. We transfected WT primary fibroblasts with this RNA reporter construct to monitor p53 IRES activity after selection of RAS-infected cells ( Figure 3B ; Supplementary Figure S2A and B). We observed that p53 IRES activity is greatly induced as cells undergo senescence ( Figure 3B ; Supplementary Figure S2A ). We next explored the possibility that p53 IRES-mediated translation may be impaired in DKC1 m cells. To this end, we compared p53 IRES-dependent translation in WT and DKC1 m RAS-infected cells. Strikingly, we found that p53 IRES activity is reduced in DKC1 m cells ( Figure 3C ). Therefore, p53 IRES-dependent translation is active during OIS and is impaired in DKC1 m cells, which show reduced p53 protein levels.
p53 IRES-mediated translation and function are impaired in DKC1 m cells after DNA damage and mitosis
To further analyse the relationship between DKC1 and p53 activation, we measured p53 protein levels during conditions that promote IRES-mediated translation, such as mitosis and DNA damage. Translational control is important in modulating cellular levels of the p53 tumour suppressor protein after DNA damage (Takagi et al, 2005; Halaby and Yang, 2007; Ofir-Rosenfeld et al, 2008) and the p53 IRES element has an important function in stimulating p53 synthesis after treatment with DNA-damaging agents (Ray et al, 2006; Yang et al, 2006) . We monitored p53 protein levels after DNA damage, comparing WT and DKC1 m primary cells. After 30 min of treatment with etoposide-a DNA-damaging agent that causes double-strand breaks-levels of p53 protein rapidly increase by almost eight-fold in WT cells, but this induction is markedly reduced in DKC1 m ( Figure 4A ). The reduction in p53 protein levels observed in DKC1 m cells is not due to changes in p53 transcription or protein stability ( Figure 4B and C). On the contrary, we found that on etoposide treatment, p53 IRES-dependent translation is increased in WT, but not in DKC1 m cells (P ¼ 0.0005; Figure 4D ; Supplementary Figure S4) . Importantly, the specific defect in p53 IRESmediated translation in DKC1 m cells perturbs p53 function. Indeed, we found that the transactivation of p53 target genes, namely p21 cip and Mdm2, was markedly reduced in DKC1 m cells after DNA damage ( Figure 4E ). Consistent with these It has been shown that mitotic progression depends on precise translational control that is associated with a general reduction of cap-dependent translation and a concomitant increase of IRES-mediated translation (Pyronnet et al, 2000) . We found that in cells arrested in the G2/M phase of the cell cycle, p53 protein levels were increased in WT, but not in DKC1 m cells ( Figure 5A ). On the other hand, p53 transcript levels were comparable between WT and DKC1 m cells ( Figure 5B) , and the percentage of cells in the G2/M phase was similar in both genotypes (Supplementary Figure S5) .
We took advantage of the ability to synchronize cells in a very controlled setting to perform polysome analysis. This enabled us to monitor p53 mRNA association with ribosomes at a moment when p53 protein levels are controlled through an IRES-dependent mechanism. We observed that the amount of p53 mRNA associated with fractions containing heavy polysomes is markedly reduced in DKC1 m as compared with control cells ( Figure 5C ). Conversely, we did not find any significant differences in the levels of b-actin mRNA associated with the polysomes between the two genotypes ( Figure 5C ). Altogether, these results identify a function for DKC1 in the control of p53 IRES-mediated translation and uncover a novel regulatory circuitry that contributes, at least in part, to the accumulation of p53 during specific stress conditions such as mitosis, DNA damage, and in response to oncogenic insults. p53 expression and its pro-apoptotic activity in g-irradiated thymocytes from WT and DKC1 m mice. Importantly, we found that g-irradiation-dependent induction of p53 protein expression was drastically impaired in DKC1 m thymocytes ( Figure 6A ), whereas no differences in total p53 transcript levels were noticeable ( Figure 6B ). The induction of the two major p53 target genes, p21 and Mdm2, was also reduced in DKC1 m compared with WT cells ( Figure 6C ). To validate the consequences of these molecular defects, we assessed the levels of apoptosis in WT and DKC1 m thymi 6 h after irradiation ( Figure 6D) . Importantly, the number of DKC1 m apoptotic (TUNEL-positive) thymocytes was significantly reduced as compared with WT cells (Figure 6D ). Altogether, these data indicate that defective p53 translational control, because of impairments in DKC1 activity, is associated with defects in p53 tumour suppressive function in vivo.
X-DC human patient lymphoblasts show impaired p53 IRES-dependent translation
We next asked whether p53 IRES-mediated translation might be impaired in human patient cells that harbour point mutations in the DKC1 gene. We transfected control and X-DC lymphoblasts carrying a missense mutation leading to the amino-acid change T66A (DKC1 T66A ) (Knight et al, 1999) with the p53 dicistronic RNA reporter construct to monitor p53 IRES activity. We found that X-DC patient cell lines display impaired p53 IRES-mediated translation compared to controls ( Figure 7A; Supplementary Figure S6) . Accordingly, p53 protein levels were also reduced in the same X-DC patient cells and, most importantly, overexpression of an exogenous WT DKC1 (DKC1 WT ) completely restored p53 expression to levels of normal cells ( Figure 7B ). Furthermore, we found that induction of p53 expression was significantly hampered in X-DC lymphoblasts after etoposide treatment ( Figure 7C ). Similarly, we analysed early passage X-DC (GM01774) fibroblasts, which bear a distinct DKC1 mutation, a deletion of L37 (del37L referred to as DKC1 L37del ), and found that p53 levels were also decreased both at the steady state and after DNA damage ( Figure 7D ), which is consistent with our in vivo analysis in DKC1 m mice. Taken together, these results suggest that impairments in DKC1 function also lead to defects in p53 IRES-dependent activity in X-DC human patient cells. Therefore, p53 IRES-mediated translation may represent one of the molecular underpinnings leading to increased cancer susceptibility in X-DC pathogenesis.
Discussion
A growing number of human syndromes including Diamond Blackfan anaemia, Shwachman-Bodian-Diamond syndrome, and X-DC are characterized by defects in ribosome biogenesis and function and are associated with increased cancer susceptibility Ganapathi and Shimamura, 2008; Alter et al, 2009) . The molecular mechanisms that may account for increased cancer susceptibility as a consequence of impairments in ribosome activity remain poorly understood. In this study, we identified a translational switch from cap-to IRES-mediated translation in primary cells transduced with activated oncogenic RAS. This finding suggests that the 
p53/β-actin Figure 7 p53 IRES-mediated translation is impaired in human cells derived from X-DC patients. (A) Normal control (Coriell # GM11626) and X-DC human lymphoblasts derived from two affected brothers carrying the missense mutation T66A (Coriell # GM3193 and GM3195) were electroporated with the dicistronic reporter mRNA harbouring a p53 IRES element. The FL/RL ratio was measured 6 h after transfection. Graph is mean ± s.e.m. of FL/RL ratios measured in three independent experiments performed in duplicate (*P ¼ 0.015 and **P ¼ 0.005). (B) Normal control and X-DC lymphoblasts were electroporated with an empty or a DKC1 WT (DKC1 WT ) expression vector and p53, DKC1, and b-actin protein levels were measured 12 h post-transfection. Representative protein analysis in one of three experiments is shown. Graph shows densitometric analysis of p53 over b-actin levels. (C) Control and X-DC lymphoblasts were cultured in the absence or presence of etoposide and harvested at the indicated time points. The p53 and b-actin protein levels are shown. (D) Normal (GM05381) and X-DC (GM01774) fibroblasts carrying a deletion of L37 in DKC1 (referred to as DKC1 L37del ) were cultured in the absence or presence of etoposide. Cells were harvested at the indicated time points and p53 and b-actin protein levels were measured. Densitometric analysis of p53 over b-actin is shown (bottom).
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synthesis of important proteins required for accurate OIS, the first cellular barrier against neoplastic transformation (Braig et al, 2005; Chen et al, 2005; Collado et al, 2005) , may be regulated at the translational level. Importantly, we found that induction of OIS is impaired in DKC1 m primary cells, which possess a specific defect in the IRES-mediated translation (Yoon et al, 2006) . Our data further show that p53, a critical mediator of OIS, is regulated at the translational level through an IRES-dependent mechanism during this critical cellular event. Moreover, DKC1 m cells show impairments in OIS that are accompanied by a significant reduction in p53 IRES-mediated translation and in the association of p53 mRNA with polysomes. The impairment in p53 expression present in DKC1 m cells was sufficient to bypass senescence, leading to a dramatic increase in the clonogenic activity of the cells on overexpression of a single oncogene. IRES-mediated translation of p53 is also activated in response to cellular stress conditions (Halaby and Yang, 2007) , and p53 IRESmediated translation is impaired after DNA damage and during the mitotic transition in DKC1 m cells. Furthermore, we show that this translational defect is associated with a severe impairment of p53 pro-apoptotic function in vivo. Importantly, human X-DC patient cells also show impairments in p53 IRES-mediated translation and display reduced p53 protein expression, which can be reverted back to normal levels by re-introduction of an exogenous form of WT DKC1, thus showing the importance of DKC1 in the regulation of p53 translational control. Therefore, modulation of p53 expression at the translation level may reflect a rapid, robust, and specific mechanism to counteract the earliest events during cellular transformation as well as during cellular stress conditions. Surprisingly, mouse cells harbouring a knock-in of a DKC1 human deletion, Dkc1 D15 , have been reported to show increased p53 expression levels (Gu et al, 2008) . The discrepancy in these findings could be explained, at least in part, if DKC1 activity is impaired to a greater extent in Dkc1 D15 cells. For example, upregulations in p53 expression could reflect an indirect stress response because of decreases in DKC1 activity below a certain threshold, as has been observed after nucleolar stress (Pestov et al, 2001; Olson, 2004) . Our results may, in part, explain what can be viewed as a paradox in X-DC pathogenesis. DKC1 has also been implicated in telomere maintenance, and X-DC patient cells show short telomeres (Mitchell et al, 1999; Ganapathi and Shimamura, 2008) . Typically, as cells undergo telomere shortening, the p53 pathway is activated by different means to prevent the development of neoplastic lesions (Artandi and Attardi, 2005) . In X-DC cells, a translational dysfunction in p53 expression may, on the contrary, promote cancer initiation even in the context of telomere shortening. The data presented in this study strongly suggest that deregulation of p53 translational control may contribute to increased cancer susceptibility in X-DC and possibly other diseases associated with ribosomal dysfunction.
Materials and methods
Transgenic mice CMV-HCV-IRES
T mice were generated using a pCMV-Myc-RL-HCV IRES-FL construct. The HCV IRES element (Yoon et al, 2006 ) was subcloned into pCR 2.1 (Invitrogen), digested with EcoRI, and inserted into a pRF plasmid. The RL-HCV IRES-FL was amplified, digested using BglII and KpnI, and inserted into the pCMV-Myc expression vector. The resulting pCMV-Myc-RL-HCV IRES-FL was linearized using an Alw44I restriction enzyme and microinjected into mouse embryos, which were then implanted into female recipient mice. Founder lines were generated, genotyped, and crossed with WT mice to verify germline transmission. To confirm that there was no splicing of the transgenic HCV IRES T dicistronic RNA, RT-PCR was performed to amplify a 1.9 kb fragment spanning from the sequence upstream of the Renilla coding region (P1) up to the Firefly coding region (P2). A second RT-PCR was carried out using primers on the Renilla (P3) and Firefly (P2) sequences to amplify a 700 bp fragment containing the HCV IRES element. The following primers were used: P1 5 0 -GCTAGCCACCATGACTTCG AAAG, P2 5 0 -GATGTTCACCTCGATATGTGC, and P3 5 0 -GTTTATT GAATCGGACCCAGG. In addition to the analysis at steady state conditions, the integrity of the endogenous transgenic HCV IRES T reporter transcript was validated during OIS. To this end, an shRNAi expression vector targeting the RLuc portion was transfected along with a b-galactosidase plasmid (for transfection efficiency) into RAS-infected HCV IRES T cells. Briefly, 100 000 RAS-infected HCV IRES T cells were plated in 6 cm plates and transfected with a scramble or an shRNAi vector targeting the RLuc sequence (GenScript) by using Lipofectamice 2000 (Invitrogen) 4 days postselection. Firefly-luciferase activity was determined using Dualluciferase kit (Promega) using a single tube luminometer (Optocomp1, MGM Instruments).
Integrity of the exogenous dicistronic p53 IRES mRNA was also tested in MEFs after etoposide-induced DNA damage and RAS expression, as well as in human X-DC patient lymphoblasts. Total RNA was isolated, retro-transcribed, and cDNA was used to amplify a 680 bp (P3-P2). Furthermore, a 1.45 kb PCR fragment spanning the p53 IRES element was amplified by using the forward primer P4 5 0 -ATGATGACTCGAAAGTTTATGATCC-3 0 along with the earlier described reverse primer P2.
Cell culture
MEFs were prepared from early generation WT, HCV IRES T , and DKC1 m male mice as described . Cells were isolated at embryonic 13.5 d.p.c. and cultured in high glucose Dulbecco Modified Eagle Media supplemented with 20% foetal bovine serum (FBS) and 100 U/ml of penicillin/streptomycin. Human control and X-DC cell lines were obtained from Coriell Cell Repositories (Coriell Institution for Medical Research, Camden, NJ). Control (GM11626) and X-DC human lymphoblasts derived from two affected brothers carrying the missense mutation T66A (GM3193 and GM3195) were maintained in RPMI supplemented with 20% FBS and 100 U/ml of penicillin/streptomycin. Similarly, human control (GM05381) and X-DC (GM01774) carrying a L37deletion (del37L) were obtained from Coriell Cell Repositories and maintained in MEM Eagle-Earle's Balance Salt Solution supplemented with non-essential amino acids, 20% FBS, and 100 U/ml of penicillin/streptomycin. All chemicals used in this study were purchased from Sigma-Aldrich unless otherwise stated.
Determination of senescence
Determination of RAS-induced senescence was carried out as described (Serrano et al, 1997) with some modifications. Briefly, early passage (p2) WT and DKC1 m MEFs were subjected to multiple rounds of infection using control or RAS high-titer viral supernatants. Infected cells were selected for 3 to 4 days in the presence of 2 mg/ml of puromycin. After selection, cells were plated at 40 Â10 3 cells/well in six-well plates (NUNC). Cellular senescence was assayed after 6 and 8 days using a Senescence Detection kit (Calbiochem) after the manufacturer's instructions. Finally, the number of senescent SA-bgal-positive cells was assessed using a Nikon TE2000E inverted microscope.
Proliferation
Cell proliferation was determined using crystal violet staining. In brief, cells were plated at 20 Â10 3 cells/well in six-well plates and stained with a 0.1% crystal violet solution. Cells were rinsed with water to remove excess dye and air dried overnight at room temperature. Finally, crystal violet was solubilized using a 10% acetic acid solution for 10 min at room temperature and the 590 nm absorbance was measured using a fluorimeter (Safire). For colony forming assays, cells were plated at 20 Â10 3 cells per 6 cm plate and cultured for 3 weeks. Cells were fixed using 70% icecold methanol, air dried, and the number of colonies was determined after staining with a 0.5% crystal violet solution.
Protein analysis
Protein analysis was performed as described (Yoon et al, 2006) according to standard protocols. Proteins were analysed by SDS-PAGE and transferred to PVDF membranes (Millipore). Antibodies and dilutions used in this study were anti-mouse p53 dilution 1:400 (CM5 Novocastra), anti-ARF 1:200 (Santa Cruz Biotechnologies), anti-RAS 1:1000 (Cell Signaling), anti-DKC1 1:200 (Santa Cruz Biotechnologies), and anti-b-actin 1:5000 (Sigma). Anti-mouse and anti-rabbit horseradish peroxidase-conjugated secondary antibodies were purchased from Amersham and used at dilution 1:10 000. Secondary anti-rat horseradish peroxidase-conjugated antibody was purchased from Cell Signaling and used at 1:5000. Enhanced chemiluminescent solution was purchased from Pierce.
mRNA quantification by Q-PCR Total RNA was purified using an RNAeasy kit (Qiagen) according to the manufacturer's instructions, and 1 mg was used for retrotranscription using the Superscript III-First-Strand cDNA Synthesis System (Invitrogen). Real-time Q-PCR was performed using SYBr green master mix (Applied Biosystem) and reactions were run on a real-time PCR system 7300 (Applied Biosystem). The following primers were used in this study: p53 
p53 IRES dicistronic reporter assay
The p53 IRES element was subcloned into the pRF dicistronic vector as described elsewhere (Ray et al, 2006; Chaudhuri et al, 2007) . Measurement of p53 IRES-mediated translation was carried out as previously reported with some modifications (Yoon et al, 2006) . Briefly, the pR-p53 IRES-F dicistronic plasmid was linearized using BamHI, and in vitro transcription of capped RNA was carried out using the mMessage mMachine T7 (Ambion) according to the manufacturer's instructions. Cells were plated at 100 Â10
